TrialClinical cancer research : an official journal of the American Association for Cancer Research2022

Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2- ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.

Massimo Cristofanilli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.